Unknown

Dataset Information

Methylation of the RARB gene increases prostate cancer risk in black Americans.


ABSTRACT:

Purpose

Gene promoter hypermethylation may be useful as a biomarker for cancer risk in histopathologically benign prostate specimens.

Materials and methods

We performed a nested case-control study of gene promoter methylation status for 5 genes (APC, RARB, CCND2, RASSF1 and MGMT) measured in benign biopsy specimens from 511 prostate cancer case-control pairs. We estimated the overall and race stratified risk of subsequent prostate cancer associated with methylation status.

Results

On race stratified analysis RARB methylation was associated with a higher cancer risk in black American men (OR 2.18, 95% CI 1.39-3.44). APC methylation was associated with an increased risk of high grade tumors (OR 2.43, 95% CI 1.20-4.90), which was higher in black than in white men (OR 3.2

SUBMITTER: Tang D 

PROVIDER: S-EPMC3779133 | biostudies-literature | 2013 Jul

REPOSITORIES: biostudies-literature